Core Laboratories (CLB) Stock Statistics & Valuation Metrics

Core Laboratories has a market cap or net worth of $867.94M. The enterprise value is $1.05B.

Core Laboratories has 46,563,390 shares outstanding. The number of shares has decreased by -2.65% in one year.

Core Laboratories’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 6.75%.

The current PE Ratio of Core Laboratories is 27.9. Core Laboratories’s PEG ratio is 15.70.

In the last 12 months, Core Laboratories had revenue of 526.52M and earned 31.80M in profits. Earnings per share was 0.68.

In the last 12 months, operating cash flow was 37.80M and capital expenditures -14.85M, giving a free cash flow of 22.95M billion.

Core Laboratories pays an annual dividend of $0.01, resulting in a dividend yield of 0.24%

Core Laboratories upcoming earnings date is Apr 29, 2026, After Close (Confirmed).

Core Laboratories as a current ratio of 2.07, with Debt / Equity ratio of 73.75%

In the past 12 months, Core Laboratories has paid 13.37M in taxes.

Core Laboratories EV to EBITDA ratio is 12.20, with an EV/FCF ratio of 41.12.

Core Laboratories has $22.85M in cash and marketable securities with $206.33M in debt, giving a net cash position of -$183.48M billion.

Gross margin is 17.65%, with operating margin of 9.28%, and net profit margin of 6.04%.

The average price target for Core Laboratories is $11.50, which is 11.43% higher than the current price. The consensus rating is Moderate Sell